Cargando…
Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
Antimicrobial resistance is a global public health threat due to its associated increase in mortality, and the most appropriate treatment algorithms for resistant and persistent Gram-positive and Gram-negative infections have yet to be elucidated. Whilst combination therapy has been touted as a viab...
Autores principales: | FakhriRavari, Alireza, Simiyu, Brenda, Morrisette, Taylor, Dayo, Yewande, Abdul-Mutakabbir, Jacinda C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798368/ https://www.ncbi.nlm.nih.gov/pubmed/35145558 http://dx.doi.org/10.7573/dic.2021-8-9 |
Ejemplares similares
-
608. Evaluation of Safety of High-Dose Beta-Lactam Antibiotics in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study
por: Varona, Jerald, et al.
Publicado: (2022) -
Leveraging Black pharmacists to promote equity in COVID‐19 vaccine uptake within Black communities: A framework for researchers and clinicians
por: Abdul‐Mutakabbir, Jacinda C., et al.
Publicado: (2022) -
Exploring the intersection of racism, antimicrobial resistance, and vaccine equity
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2022) -
Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection
por: FakhriRavari, Alireza, et al.
Publicado: (2016) -
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives
por: Garcia-Bustos, Víctor, et al.
Publicado: (2022)